Checked against public sources between July 23 and July 24, 2026 · LookCloser does not sell or recommend supplements.
Does the marketing hold up?
EPA + DHA dose is within one studied range. This lines up the amount on the label with the range used in the linked studies.
“Couldn’t verify” means we looked and found no public proof — not a mark against the product. Most supplement claims cannot be independently verified by anyone, so grey is the normal state of this industry.
| Calories | 6 |
|---|---|
| Total Fat | 0.5 g |
| Cholesterol | 0 mg |
| Concentrated Fish Oil | 625 mg |
| EPA (Eicosapentaenoic Acid) | 375 mg |
| DHA (Docosahexaenoic Acid) | 125 mg |
| Vitamin D3 | 50 mcg (2000 IU) |
| Vitamin K2 (MenaQ7®) | 80 mcg |
Printed on the package: MSC certified · MADE IN USA
We read 8 lines from the package photograph. It is our transcript of the label, not the manufacturer’s panel, and it may be incomplete.
The public sources did not settle the marketing promises on this label.
The panel lists 500 mg EPA + DHA per serving (1 Softgel). One randomized dose-response trial used 300–1,800 mg/day; omega-3 studies vary widely. This is research context, not a recommendation or safety verdict.
Ingredient research can support context, but it is not a trial of this exact product.
“Made in USA” can describe only final bottling. Ingredient-sourcing records were not located for this product.
We looked and found no public proof. That does not count against the product.
Headlines first. Open evidence only when you want the source trail.
Every ingredient shows its real amount — nothing is hidden in a proprietary blend.
The panel gives a per-ingredient amount rather than hiding quantities inside a proprietary blend, so each one can be compared to published research.
Locked evidence record →Open the full source-linked findingA government label filing makes the listed formula easier to inspect and compare over time.
Label #81406 “Wild Alaskan Fish Oil Peak EPA” (Wiley's Finest ), entered 2017-12-22, with the full Supplement Facts on file. Company on file: Manufacturer — Wiley's Finest, Coshocton, OH, 43812.
Locked evidence record →Open the full source-linked findingThese are evidence gaps, not strikes against the product.
Filed address
545 Walnut Street, Coshocton, OHIO 43812, UNITED STATES
USPTO identifies the public owner or applicant behind this brand wordmark. This does not by itself identify the product manufacturer or prove where the product was made. Open USPTO source ↗
The label amount is shown beside the range used in the linked ingredient studies.
500 mg per serving — within the 300–1800 mg/day used in the linked studies.
Not a score. Studies disagree with each other and change over time, so this sits beside the evidence rather than counting toward it — it is here so you can read the sources yourself.
The panel lists 375 mg of omega-3 (EPA + DHA) per serving. Studies we found used 300 mg–1.8 g a day, so this sits inside that range.
Study ranges differ between trials and change as research changes. This is background reading, not a pass, a failure, or a recommendation.
$0.61 per labeled serving
matching UPC/GTIN · checked Aug 29, 2026
View on Amazon ↗$0.61 per labeled serving
matching UPC/GTIN · checked Jul 24, 2026
View on iHerb ↗We only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.
Search Target ↗We only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.
Search Walmart ↗Same UPC/GTIN observed across 2 sellers at the same price at check time.
Reference prices only · no affiliate links · every compared seller must publish the matching UPC/GTIN.
The summary stops at product-specific facts. The full report preserves every source, calculation, limitation, and unresolved check for review or sharing.
Record built September 03, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.